MSB 3.42% $1.21 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-1519

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi Imback,
    With 500 deaths a day and with some excellent results from the ARDs trial you think they will wait until GvHD is approved in 6 months.

    Iam not sure about that.
    Remember the NIH funded this trial for a pandemic.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.